Our Other Prescription Drug Problem
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The adverse effects of benzodiazepine overuse, misuse, and addiction continue to go largely unnoticed. Efforts to reduce overprescribing of opioids and educate the medical and lay communities about their risks could be expanded to target benzodiazepines as well.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, the issue of long-term use persists in many nations and has been prominently referred to as ‘our other prescription drug problem’ beyond opioids.13,14”
Citations
Cites
Sun, E. C., Dixit, A., Humphreys, K., Darnall, B. D., Baker, L. C., & Mackey, S. (2017) · BMJ · doi:10.1136/bmj.j760 · Cited by 534
Self-citationIncreasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996–2013
Bachhuber, M. A., Hennessy, S., Cunningham, C. O., & Starrels, J. L. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303061 · Cited by 531
Dowell, D., Zhang, K., Noonan, R. K., & Hockenberry, J. M. (2016) · Health Affairs · doi:10.1377/hlthaff.2016.0448 · Cited by 264
Utilization, Spending, and Price Trends for Benzodiazepines in the US Medicaid Program: 1991-2009
Gorevski, E., Bian, B., Kelton, C. M. L., Martin-Boone, J. E., & Guo, J. J. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q618 · Cited by 34
Factors associated with benzodiazepine prescribing in community mental health settings
Jessell, L., Stanhope, V., Manuel, J. I., & Mateu‐Gelabert, P. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.10.001 · Cited by 15
Benzodiazepine and antipsychotic medication use in older adults
Neft, M., Oerther, S. E., Halloway, S., HANNEMAN, S. K. G., & Mitchell, A. M. (2019) · Nursing Open · doi:10.1002/nop2.425 · Cited by 5
Cited by
Humphreys, K., Shover, C. L., Andrews, C. M., Bohnert, A. S. B., Brandeau, M. L., Caulkins, J. P., Chen, J. H., Cuéllar, M.-F., Hurd, Y. L., Juurlink, D. N., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02252-2 · Cited by 421
Self-citationThe epidemiology of benzodiazepine misuse: A systematic review*
Votaw, V. R., Geyer, R., Rieselbach, M. M., & McHugh, R. K. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.02.033 · Cited by 479
Benzodiazepine Use and Misuse Among Adults in the United States
Maust, D. T., Lin, L. A., & Blow, F. C. (2019) · Psychiatric Services · doi:10.1176/appi.ps.201800321 · Cited by 337
“Concerns related to benzodiazepine prescribing have spread beyond just older adults or coprescribing with opioids (12).”
BackgroundPatterns in Outpatient Benzodiazepine Prescribing in the United States
Agarwal, S. D., & Landon, B. E. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.7399 · Cited by 319
Current Clinical Landscape and Global Potential of Bacteriophage Therapy
Hitchcock, N. M., Devequi Gomes Nunes, D., Shiach, J., Valeria Saraiva Hodel, K., Dantas Viana Barbosa, J., Alencar Pereira Rodrigues, L., Coler, B. S., Botelho Pereira Soares, M., & Badaró, R. (2023) · Viruses · doi:10.3390/v15041020 · Cited by 187
Shover, C. L., Falasinnu, T. O., Dwyer, C. L., Santos, N. B., Cunningham, N. J., Freedman, R. B., Vest, N. A., & Humphreys, K. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108314 · Cited by 162
Self-citationMarketplaces, Markets, and Market Design
Roth, A. E. (2018) · American Economic Review · doi:10.1257/aer.108.7.1609 · Cited by 187
EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke
Bassetti, C. L. A., Randerath, W., Vignatelli, L., Ferini-Strambi, L., Brill, A.-K., Bonsignore, M. R., Grote, L., Jennum, P., Leys, D., Minnerup, J., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01104-2019 · Cited by 132
EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke
Bassetti, C. L. A., Randerath, W., Vignatelli, L., Ferini‐Strambi, L., Brill, A. ‐., Bonsignore, M. R., Grote, L., Jennum, P., Leys, D., Minnerup, J., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14201 · Cited by 109
“Insomnia affects over 20% of the general population and up to 5%–10% use hypnotics [13], with a tendency in recent years to an increase in some countries including the USA and an increase in benzodiazepinerelated deaths [14].”
BackgroundOstuzzi, G., Papola, D., Gastaldon, C., Schoretsanitis, G., Bertolini, F., Amaddeo, F., Cuomo, A., Emsley, R. A., Fagiolini, A. M., Imperadore, G., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01685-9 · Cited by 110
Sidorchuk, A., Isomura, K., Molero, Y., Hellner, C., Lichtenstein, P., Chang, Z., Franck, J., de la Cruz, L. F., & Mataix‐Cols, D. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002635 · Cited by 102
Endozepines and their receptors: Structure, functions and pathophysiological significance
Tonon, M.-C., Vaudry, H., Chuquet, J., Guillebaud, F., Fan, J., Masmoudi-Kouki, O., Vaudry, D., Lanfray, D., Morin, F., Prevot, V., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.06.008 · Cited by 71
Brandt, J., Bressi, J., Lê, M.-L., Neal, D., Cadogan, C., Witt-Doerring, J., Witt-Doerring, M., & Wright, S. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102507 · Cited by 77
“13,14 The public health implications for BZD & BZRA use are continuously being revised in light-of newer phar-macoepidemiologic studies and patient engagement research both of which elucidate these issues in greater detail.”
BackgroundBenzodiazepines and Related Sedatives
Peng, L., Morford, K. L., & Levander, X. A. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.08.012 · Cited by 86
Regulation of GABAARs by Transmembrane Accessory Proteins
Han, W., Shepard, R. D., & Lü, W. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.10.011 · Cited by 60
Sigurdsson, M. I., Helgadóttir, S., Long, T. E., Helgason, D., Waldron, N. H., Pálsson, R., Indridason, Ó. S., Guðmundsdóttir, I. J., Guðbjartsson, T., & Sigurdsson, G. H. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2019.1652 · Cited by 58
“Age, mean (SD), y 55 (19) 57 (17) 63 (16) 61 (15) <.”
Fegadolli, C., Varela, N. M. D., & Carlini, E. A. (2019) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00097718 · Cited by 57
Benzodiazepine-Involved Overdose Deaths in the USA: 2000–2019
Kleinman, R. A., & Weiss, R. D. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-021-07035-6 · Cited by 50
Maust, D. T., Petzold, K., Strominger, J., Kim, H. M., & Bohnert, A. S. B. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.48557 · Cited by 47
Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis
Cunliffe, J., Décary-Hêtu, D., & Pollak, T. A. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.01.016 · Cited by 44
Advise non-pharmacological therapy as first line treatment for chronic insomnia
Soong, C., Burry, L. D., Greco, M., & Tannenbaum, C. (2021) · BMJ · doi:10.1136/bmj.n680 · Cited by 40
Shaw, J. C., Murphy, A. L., Turner, J. P., Gardner, D. M., Silvius, J. L., Bouck, Z., Gordon, D., & Tannenbaum, C. (2019) · Healthcare policy · doi:10.12927/hcpol.2019.25857 · Cited by 40
“…falls and fractures (Donnelly et al. 2017; Woolcott et al. 2009), cognitive impairment (Billioti de Gage et al. 2012; Tannenbaum et al. 2012), automobile accidents (Hansen et al. 2015) and higher mortality alone and in combination with opioids (Kripke 2016; Lembke et al. 2018; Sun et al. 2017).”
BackgroundBrandt, J., Alessi‐Severini, S., Singer, A. G., & Leong, C. (2019) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.22374/1710-6222.26.1.3 · Cited by 46
Preoperative Sedative-hypnotic Medication Use and Adverse Postoperative Outcomes
Gaulton, T. G., Wunsch, H., Gaskins, L. J., Leonard, C. E., Hennessy, S., Ashburn, M. A., Brensinger, C. M., Newcomb, C., Wijeysundera, D. N., Bateman, B. T., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003556 · Cited by 38
“These findings mirror prior research indicating substantially higher rates of prevalent benzodiazepine and Z-drug use among chronic opioid users compared to the rest of the population.(1,7) Our finding that concurrent prescribing of benzodiazepines and Z-drugs with opioids is associated with increased risks of postope…”
BackgroundResultDemographics, Perceptions, and Use of Medical Marijuana among Patients in Florida
Rosenthal, M. S., & Pipitone, R. N. (2020) · Medical Cannabis and Cannabinoids · doi:10.1159/000512342 · Cited by 37
Friedrich, J., Sun, C., Geng, X., Calello, D. P., Gillam, M. P., Medeiros, K. L., Stafford‐Smith, M., Ruck, B. E., & Mazer-Amirshahi, M. E. (2019) · Clinical Toxicology · doi:10.1080/15563650.2019.1674321 · Cited by 37
“The literature reports that benzodiazepines overdose is typically not life-threatening in isolation [5], and our findings reflect the concept that co-ingestion of one or more substances increases the severity of exposure outcome (Table 3) [8,15].”
BackgroundSchuster, J., Hoertel, N., von Gunten, A., Seigneurie, A.-S., & Limosin, F. (2019) · International Psychogeriatrics · doi:10.1017/s1041610219000358 · Cited by 38
Complex Persistent Benzodiazepine Dependence—When Benzodiazepine Deprescribing Goes Awry
Peng, L., Meeks, T. W., & Blazes, C. K. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.1150 · Cited by 35
Overdose deaths involving non-BZD hypnotic/sedatives in the USA: Trends analyses
Tardelli, V. S., Bianco, M. C. M., Prakash, R., Segura, L. E., Castaldelli-Maia, J. M., Fidalgo, T. M., & Martins, S. S. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100190 · Cited by 36
Prescription Benzodiazepine Use in Privately Insured U.S. Children and Adolescents
Bushnell, G., Crystal, S., & Olfson, M. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.07.006 · Cited by 29
Davies, J., Cooper, R. E., Moncrieff, J., Montagu, L., Rae, T. C., & Parhi, M. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107143 · Cited by 30
Azad, T. D., Zhang, Y., Stienen, M. N., Vail, D. G., Bentley, J., Ho, A. L., Fatemi, P., Herrick, D. B., Kim, L. H., Feng, A. Y., et al. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05549-8 · Cited by 29
Self-citationRishel, C. A., Zhang, Y., & Sun, E. C. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.18761 · Cited by 29
Sleep promoting and omics exploration on probiotics fermented Gastrodia elata Blume
Zhang, C.-Q., Zhang, X.-D., Wang, Y., Liu, Y., Zhang, Q., & Zhang, Q. (2024) · npj Science of Food · doi:10.1038/s41538-024-00277-8 · Cited by 26
“Overdose deaths involving benzodiazepines increased between 1999 and 2015 14 .”
Rodda, L. N. (2024) · Addiction · doi:10.1111/add.16520 · Cited by 25
U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016
Geller, A. I., Dowell, D., Lovegrove, M. C., McAninch, J., Goring, S. K., Rose, K. O., Weidle, N. J., & Budnitz, D. S. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.12.009 · Cited by 24
Patterns of Polysubstance Use among Adults with Tranquilizer Misuse
Votaw, V. R., McHugh, R. K., Vowles, K. E., & Witkiewitz, K. A. (2020) · Substance Use & Misuse · doi:10.1080/10826084.2019.1708118 · Cited by 23
Kimani, M. M., Lanzarotta, A. C., & Batson, J. S. (2021) · Journal of Forensic Sciences · doi:10.1111/1556-4029.14797 · Cited by 23
“Benzodiazepines belong to a class of drug compounds referred to as sedative hypnotic agents that have several different therapeutic uses including treatment of anxiety disorders, insomnia, seizure disorders, alcohol withdrawal symptoms, and for conscious sedation or general anesthesia [1,2].”
BackgroundAmundsen, E. J., Bretteville‐Jensen, A. L., & Rossow, I. M. (2022) · BMC Public Health · doi:10.1186/s12889-022-13199-5 · Cited by 23
Maust, D. T., Bohnert, A. S. B., Strominger, J., Alexander, N. B., Min, L. C., Hoffman, G. J., & Goldstick, J. E. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03497-3 · Cited by 22
“Expert opinion and professional guidelines suggest that short-term or intermittent BZD use is safer [8, 10, 11], yet few data support this.”
BackgroundQato, D. M., & Gandhi, A. B. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-03787-5 · Cited by 22
“The increasing use of benzodiazepines is compelling to consider as a parallel problem to the opioid crisis [37].”
BackgroundBenzodiazepine use disorder: A cross-sectional study at a tertiary care center in Lebanon
Zahran, T. E., Kanaan, E., Kobeissi, L., Bouassi, J., Sarieddine, A., Carpenter, J. E., Kazzi, Z., & Hitti, E. A. (2022) · Medicine · doi:10.1097/md.0000000000030762 · Cited by 21
Benzodiazepines: the time for systematic change is now
Schmitz, A. (2020) · Addiction · doi:10.1111/add.15095 · Cited by 21
Benzodiazepine Use and Dependence in Relation to Chronic Pain Intensity and Pain Catastrophizing
Lape, E. C., Powers, J. M., Hooker, J. E., Edwards, R. R., & Ditre, J. W. (2022) · Journal of Pain · doi:10.1016/j.jpain.2022.09.019 · Cited by 22
“, 2019), there is a call to curb overprescription (Lembke et al., 2018) and elucidate biopsychosocial factors contributing to BZD overuse and misuse (Rigg & Ford, 2014).”
BackgroundOstroumov, A., Wittenberg, R. E., Kimmey, B. A., Taormina, M. B., Holden, W. M., McHugh, A. T., & Dani, J. A. (2020) · eNeuro · doi:10.1523/eneuro.0348-19.2020 · Cited by 24
“Among the different classes of GABAAR-targeting drugs, benzodiazepine misuse is a growing public health problem in the United States, with prescription rates and overdose mortality spiking in recent years (Bachhuber et al., 2016; Lembke et al., 2018; Maust et al., 2019).”
BackgroundBenzodiazepine use before conception and risk of ectopic pregnancy
Wall‐Wieler, E., Robakis, T. K., Lyell, D. J., Masarwa, R., Platt, R. W., & Carmichael, S. L. (2020) · Human Reproduction · doi:10.1093/humrep/deaa082 · Cited by 20
Cucciare, M. A., Abraham, T. H., Kemp, L., White, P., Marchant, K., Hagedorn, H. J., & Humphreys, K. (2022) · Journal of Medical Internet Research · doi:10.2196/35514 · Cited by 18
“Long-term dependence on prescribed benzodiazepines is a public health problem in multiple countries, including the United Kingdom and the United States [1-4].”
Self-citationRousselot, N., Pariente, A., Mansiaux, Y., & Victorri‐Vigneau, C. (2020) · The Annals of Family Medicine · doi:10.1370/afm.2556 · Cited by 16
Normal complications and abnormal assumptions after perinatal death
Cacciatore, J., & Thieleman, K. (2019) · MCN The American Journal of Maternal/Child Nursing · doi:10.1097/nmc.0000000000000486 · Cited by 15
Ostuzzi, G., Papola, D., Gastaldon, C., Schoretsanitis, G., Bertolini, F., Amaddeo, F., Cuomo, A., Emsley, R. A., Fagiolini, A. M., Imperadore, G., et al. (2020) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.18308 · Cited by 17
Civil Commitment for Substance Use Disorders: A National Survey of Addiction Medicine Physicians
Jain, A., Christopher, P. P., Fisher, C. E., Choi, C. J., & Appelbaum, P. S. (2021) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000847 · Cited by 15
“Benzodiazepines have also increasingly contributed to overdose deaths.(3) Poor appreciation of treatment need among individuals with SUDs and the recent rise of SUDs and overdose deaths have prompted more states to consider civil commitment (CC) for SUD laws.”
BackgroundFactors associated with benzodiazepine prescribing in community mental health settings
Jessell, L., Stanhope, V., Manuel, J. I., & Mateu‐Gelabert, P. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.10.001 · Cited by 15
Can Policy Affect Initiation of Addictive Substance Use? Evidence from Opioid Prescribing
Sacks, D. W., Hollingsworth, A. J., Nguyen, T. D., & Simon, K. I. (2019) · National Bureau of Economic Research · doi:10.3386/w25974 · Cited by 14
Chronic use of benzodiazepines: the problem that persists
Louie, D. L., Jegede, O. O., & Hermes, G. L. (2023) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174231166252 · Cited by 13
“Chronic benzodiazepine use has been labeled a “hidden epidemic,” not because it is a secret but rather because of the surprising lack of attention it garners.(1) Benzodiazepines have been implicated in a number of serious adverse effects, including cognitive and psychomotor impairment, increased fall risk, dependence,…”
BackgroundLi, C., Santaella-Tenorio, J., Mauro, P. M., & Martins, S. S. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.04.029 · Cited by 14
“7 per 100,000) between 2004 and 2011 (Bachhuber et al., 2016; Jones and McAninch, 2015; Lembke et al., 2018).”
Coleman, R. B., Aguirre, K. N., Spiegel, H. P., Pecos, C., Carr, J. A., & Harris, B. N. (2019) · Journal of Comparative Physiology A · doi:10.1007/s00359-019-01351-3 · Cited by 12
Mallah, N., Rodríguez‐Cano, R., Figueiras, A., & Takkouche, B. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108730 · Cited by 12
Pawson, M., & Kelly, B. C. (2022) · Sociological Forum · doi:10.1111/socf.12778 · Cited by 12
Policy Responses to the Addiction Crisis
Frank, R. G., Humphreys, K. N., & Pollack, H. A. (2021) · Journal of Health Politics Policy and Law · doi:10.1215/03616878-8970796 · Cited by 11
Self-citationCogan, J. C., Raghunathan, R. R., Beauchemin, M., Accordino, M. K., Elkin, E. B., Melamed, A., Wright, J. D., & Hershman, D. L. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06275-8 · Cited by 12
Kim, H. S., Kaplan, S., McCarthy, D. M., Pinto, D., Strickland, K. J., Courtney, D. M., & Lambert, B. L. (2018) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2018.10.009 · Cited by 11
“We included benzodiazepines due to their common use for relief of back pain [14,24-26].”
BackgroundLiu, E. Y., Tamblyn, R. M., Filion, K. B., & Buckeridge, D. L. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-042299 · Cited by 10
Peng, L., Lawrence, D. M., & Levander, X. A. (2021) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000869 · Cited by 11
Ketamine and rapidly acting antidepressants: Breaking the speed of sound or light?
Berk, M., Loo, C., Davey, C. G., & Harvey, B. H. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418783567 · Cited by 9
Tinnitus associated with benzodiazepine withdrawal syndrome: A case report and literature review
Laskey, C., & Opitz, B. J. (2020) · Mental Health Clinician · doi:10.9740/mhc.2020.05.100 · Cited by 9
“Both the risk for addiction with benzodiazepines and the increased risk for mortality when used concomitantly with opioids have driven recent scrutiny of prescribing patterns.(7,8) As prescribers weigh the risks and benefits of ongoing benzodiazepine use, care must be taken when deciding to taper and discontinue these…”
BackgroundRising Stimulant Overdoses Among Young People in the United States
Hadland, S. E., & Marshall, B. D. L. (2020) · PEDIATRICS · doi:10.1542/peds.2020-031526 · Cited by 9
New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer
Cogan, J. C., Raghunathan, R. R., Beauchemin, M., Accordino, M. K., Huang, Y., Elkin, E. B., Melamed, A., Wright, J. D., & Hershman, D. L. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac170 · Cited by 9
Opioid use and risks in candidates and recipients of liver transplant
Rubin, J. B., Aby, E. S., Barman, P. M., & Tincopa, M. A. (2024) · Liver Transplantation · doi:10.1097/lvt.0000000000000388 · Cited by 9
“Given the prevalence of benzodiazepine use and the potential for adverse outcomes associated with benzodiazepine and opioid co-prescription, [36] we will briefly comment on opioid and benzodiazepine co-prescription in patients who received LT.”
Best practices in benzodiazepine prescribing and management in primary care
Champion, C., & Kameg, B. (2021) · The Nurse Practitioner · doi:10.1097/01.npr.0000733684.24949.19 · Cited by 9
The incidence of new and persistent benzodiazepine use after surgery
Albertsson, Þ. Í., Jónsdóttir, F., Kárason, S., & Sigurdsson, M. I. (2023) · Surgery · doi:10.1016/j.surg.2022.12.024 · Cited by 8
Krieger, A. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1569416 · Cited by 7
““ Many prescribers, ” they claim, “ don ’ t realize that benzodiazepines can be addictive and when taken daily can worsen anxiety, contribute to persistent insomnia, and cause death ” (10, 694).”
An Intervention to Decrease Benzodiazepine Prescribing by Providers in an Urban Clinic
Platt, L. M., Savage, T. A., & Rajagopal, N. (2020) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20191218-08 · Cited by 7
Sankar, K., Shanmugasundram, N., Baskaran, B., Anabalagan, D., Sivaraman, V., Santhiyagu, X., & Rajanandh, M. G. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.10.010 · Cited by 7
Older adults’ perceptions of deprescribing chronic benzodiazepines
Choi, J., & Vordenberg, S. E. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.04.003 · Cited by 10
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling
Higgins, M. J., Yan, X., & Chatterjee, C. (2020) · Research Policy · doi:10.1016/j.respol.2020.104126 · Cited by 7
Benzodiazepine exposures among women of reproductive age in the US, 2004–2018
Michaels, N. L., Spiller, H., Badeti, J., Sheftall, A., Funk, A., & Smith, G. A. (2021) · Human & Experimental Toxicology · doi:10.1177/09603271211013431 · Cited by 9
Lee, J., Salloum, R. G., Lindstrom, K., & McHugh, R. K. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107058 · Cited by 7
Yoon, J. M., Trinkoff, A. M., Galik, E. M., Storr, C. L., Lerner, N. B., Brandt, N., & Zhu, S. (2022) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2022.04.006 · Cited by 7
Krüger, C., Lindberg, M. H., Burmester, S., Franck, J., & Westman, J. (2025) · BMC Public Health · doi:10.1186/s12889-025-23920-9 · Cited by 8
“…long-term use—defined as use for six months or more within a year [6, 8]— is estimated to be 3% of the population in Sweden [8] and internationally [1–3, 9] , and When benzodiazepines were first introduced in the 1950s, they were generally marketed as being non-addic-tive, and these attitudes…”
Weleff, J., Anand, A., Squeri, M., Sieke, R., Thompson, N. R., & Barnett, B. S. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2191610 · Cited by 9
“While oversha-dowed by the unfolding ramifications of widespread opioid prescribing in the early 2000s, excessive benzo-diazepine prescribing has become a growing concern within American medicine (Lembke, Papac, and Humphreys 2018).”
BackgroundSeddon, J. L., Friedrich, C., Wadd, S., Dicks, D., Scott, S., Robinson, A., & Walker, C. (2024) · BMC Family Practice · doi:10.1186/s12875-023-02253-9 · Cited by 6
Sacarny, A., Safran, E., Steffel, M., Dunham, J. R., Abili, O. D., Mohajeri, L., Oh, P. T., Sim, A., Brutcher, R. E., & Spevak, C. (2022) · JAMA Health Forum · doi:10.1001/jamahealthforum.2022.3378 · Cited by 7
Management of unspecified anxiety disorder: Expert consensus
Sakurai, H., Inada, K., Aoki, Y., Takeshima, M., Ie, K., Kise, M., Yoshida, E., Tsuboi, T., Yamada, H., Hori, H., et al. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12323 · Cited by 7
Bensley, K. M., Kerr, W. C., Barnett, S. B. L., & Mulia, N. (2021) · The Journal of Rural Health · doi:10.1111/jrh.12574 · Cited by 6
Mallah, N., Figueiras, A., Miri, H. H., & Takkouche, B. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108793 · Cited by 6
Toce, M. S., Michelson, K. A., Hudgins, J. D., Olson, K. L., Monuteaux, M. C., & Bourgeois, F. T. (2023) · Clinical Toxicology · doi:10.1080/15563650.2023.2181092 · Cited by 7
“The majority of work examining the current drug overdose epidemic in the US has focused on opioid-related harms, but benzodiazepines have emerged as an important class of medications contributing to drug-related morbidity and mortality [23].”
BackgroundBenzodiazepine and Nonbenzodiazepine Hypnotics (Z-Drugs): The Other Epidemic
Umbricht, A., & Vélez, M. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_11 · Cited by 8
Lin, W., Qin, Y., & Ren, Y. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.122949 · Cited by 5
Treating Insomnia in Older Adult Patients: Limiting Benzodiazepine Use
Pergolizzi, J. V., Taylor, R. J., LeQuang, J. A., Gould, E. M., & Raffa, R. B. (2019) · Pharmacology & Pharmacy · doi:10.4236/pp.2019.103010 · Cited by 5
Opioid deaths in Ontario, Canada
Hadland, S. E., & Kertesz, S. G. (2018) · BMJ · doi:10.1136/bmj.k3537 · Cited by 5
Benzodiazepine and antipsychotic medication use in older adults
Neft, M., Oerther, S. E., Halloway, S., HANNEMAN, S. K. G., & Mitchell, A. M. (2019) · Nursing Open · doi:10.1002/nop2.425 · Cited by 5
“Daily living should be structured so that demands or challenges are within manageable limits, and a positive atmosphere is created (Lyketsos et al., 2006).”
BackgroundBråbäck, M., Brantefors, A., Franck, J., Brådvik, L., Isendahl, P., Nilsson, S., Troberg, K., & Håkansson, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19020697 · Cited by 4
Taipale, H. T., Tanskanen, A. J., Kurko, T., Taiminen, T. J., Särkilä, H., Tiihonen, J., Sund, R., Niemelä, S., Saastamoinen, L., & Hietala, J. A. (2024) · European Psychiatry · doi:10.1192/j.eurpsy.2024.1745 · Cited by 4
Expecting medication misuse: a proactive approach to drug discovery to prevent fatal overdose
Carry, E., Vasilatis, A., Johnson, A. L., & Ryan, J. W. (2025) · Future Medicinal Chemistry · doi:10.1080/17568919.2025.2476388 · Cited by 4
“Between 60% and 70% of these (58,497) deaths involved fentanyl and more than 10% (10,964) involved BZDs [16].”
Clinical Implications of the Drug-Centered Approach
Steingard, S. (2018) · Springer eBooks · doi:10.1007/978-3-030-02732-2_5 · Cited by 5
Ketamine: A Potential Adjunct for Severe Benzodiazepine Withdrawal
Purcell, K., Bianchi, P. W., Glenn, D., Blakey, B., & Motov, S. M. (2021) · Cureus · doi:10.7759/cureus.20114 · Cited by 6
“The growing number of BZD prescriptions is a concern given the abuse potential and risks associated with BZD use [9].”
BackgroundCucciare, M. A., Hagedorn, H., Bounthavong, M., Abraham, T. H., Greene, C. J., Han, X., Kemp, L., Marchant‐Miros, K., White, P. L., & Humphreys, K. N. (2022) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2022.100994 · Cited by 4
Self-citationTurpin, M. A. C., Rowland, K. C., Anugwom, C., Arocha, M., Carona, A., Gonzalez, B. I., Iskander, G., Snyder, S., Wilson, K., Kaye, A. D., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98814-8.00027-5 · Cited by 6
Maust, D. T., Bohnert, A. S. B., Strominger, J., & Goldstick, J. E. (2023) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-023-00674-x · Cited by 4
“While expert opinion and professional guidelines suggest that short-term or intermittent BZD use has a more favorable risk–benefit profile [9, 12, 13], there are few data to support this.”
BackgroundResultWolitzky-Taylor, K. B., Mooney, L. J., Otto, M. W., Metts, A. V., Parsons, E. M., Hanano, M., & Ram, R. J. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107334 · Cited by 6
Metadata
- Authors
- Lembke, A., Papac, J., & Humphreys, K.
- Affiliations
- VA Palo Alto Health Care System (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-02-22
- Volume
- 378
- Issue
- 8
- Pages
- 693-695
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2793088603
- Cited by
- 160
- References
- 6
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 16 · 2023: 19 · 2022: 19 · 2021: 29 · 2020: 24 · 2019: 26 · 2018: 12
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- benzodiazepines, benzodiazepine misuse, benzodiazepine dependence, adverse drug reactions, opioid overprescribing, prescription drug misuse, public education
- MeSH terms
- Medical Overuse, Benzodiazepines, Humans, United States, Substance-Related Disorders, Prescription Drug Misuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.